GE HealthCare Technologies’ (GEHC) “Buy” Rating Reiterated at BTIG Research

GE HealthCare Technologies (NASDAQ:GEHC)‘s stock had its “buy” rating restated by research analysts at BTIG Research in a research note issued on Tuesday,Benzinga reports. They currently have a $85.00 target price on the stock. BTIG Research’s price target points to a potential upside of 14.63% from the stock’s current price.

A number of other equities analysts have also recently weighed in on the company. UBS Group cut GE HealthCare Technologies from a “neutral” rating to a “sell” rating and lifted their price target for the stock from $73.00 to $77.00 in a research note on Thursday, January 15th. Evercore lifted their price target on GE HealthCare Technologies from $95.00 to $98.00 and gave the stock an “outperform” rating in a research note on Thursday, February 5th. Wall Street Zen cut GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, March 21st. Piper Sandler dropped their price target on GE HealthCare Technologies from $96.00 to $88.00 and set an “overweight” rating on the stock in a research note on Friday. Finally, Morgan Stanley lifted their price target on GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 4th. Eight analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $89.77.

GE HealthCare Technologies Price Performance

NASDAQ:GEHC opened at $74.15 on Tuesday. The business’s 50-day moving average price is $75.35 and its 200 day moving average price is $77.95. The firm has a market cap of $33.83 billion, a P/E ratio of 16.26, a PEG ratio of 1.64 and a beta of 1.17. GE HealthCare Technologies has a 52-week low of $59.95 and a 52-week high of $89.77. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. The firm had revenue of $5.70 billion for the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.GE HealthCare Technologies’s revenue was up 7.1% on a year-over-year basis. During the same quarter last year, the business posted $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, sell-side analysts predict that GE HealthCare Technologies will post 5 earnings per share for the current fiscal year.

Hedge Funds Weigh In On GE HealthCare Technologies

Several institutional investors and hedge funds have recently bought and sold shares of the business. Louisiana State Employees Retirement System purchased a new position in GE HealthCare Technologies during the 1st quarter valued at about $3,780,000. Fifth Third Wealth Advisors LLC grew its stake in GE HealthCare Technologies by 8.8% during the 1st quarter. Fifth Third Wealth Advisors LLC now owns 3,339 shares of the company’s stock valued at $238,000 after acquiring an additional 269 shares in the last quarter. Brown Lisle Cummings Inc. grew its stake in GE HealthCare Technologies by 29.3% during the 1st quarter. Brown Lisle Cummings Inc. now owns 706 shares of the company’s stock valued at $50,000 after acquiring an additional 160 shares in the last quarter. OP Asset Management Ltd purchased a new position in GE HealthCare Technologies during the 1st quarter valued at about $3,296,000. Finally, Banque Cantonale Vaudoise grew its stake in GE HealthCare Technologies by 16,539.1% during the 1st quarter. Banque Cantonale Vaudoise now owns 25,957 shares of the company’s stock valued at $1,849,000 after acquiring an additional 25,801 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.